Update on intravesical agents for non-muscle-invasive bladder cancer.

Immunotherapy
Shahrokh F ShariatGuido Dalbagni

Abstract

Major controversies still exist with regard to the indication, type and regimen of intravesical therapy for non-muscle-invasive bladder cancer. Other areas of controversy are the criteria for response/failure of treatment and for decisions regarding secondary intravesical therapy versus radical cystectomy. In this article, we analyze the different intravesical therapeutic strategies and compare their safety and efficacy. Well-designed clinical trials have found that the addition of bacillus Calmette-Guerin (BCG) to transurethral resection (TUR) decreases the risk for both disease recurrence and progression. These encouraging results are sustained even in patients with recurrent or aggressive disease, including patients whose prior intravesical chemotherapy has failed. Most investigators believe that the efficacy of BCG therapy can be maximized with maintenance therapy. Mitomycin C (MMC), the most commonly used intravesical chemotherapy to date, decreases the risk of disease recurrence but not disease progression when used after TUR compared with TUR alone. The oncologic efficacy of intravesical MMC can be optimized by increasing its concentration in addition to alkalinizing and reducing urine production. For patients at high ri...Continue Reading

References

Mar 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R A BadalamentH F Oettgen
Jul 1, 1985·The Journal of Urology·D L Lamm
Apr 5, 1969·Lancet·G MathéF De Vassal
Mar 1, 1996·International Journal of Urology : Official Journal of the Japanese Urological Association·D L BerryE D Crawford
Jul 1, 1997·The Journal of Urology·M S CooksonW R Fair
Nov 27, 1999·European Urology·P RischmannD K Chopin
Dec 22, 1999·The Journal of Urology·F Millán-RodríguezJ Vicente-Rodríguez
Apr 20, 2001·Journal of the National Cancer Institute·J L AuUNKNOWN International Mitomycin C Consortium
May 4, 2001·Journal of Autoimmunity·Y ShoenfeldM Ehrenfeld
Jul 10, 2001·Acta Oncologica·S NilssonUNKNOWN SBU-group. Swedish Council of Technology Assessment in Health Care
Aug 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Guido DalbagniDean Bajorin
Feb 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Menachem LauferMerrill J Egorin
Apr 11, 2003·The Journal of Urology·Harry W Herr, Guido Dalbagni
Jul 23, 2004·Aging Cell·Brian DeVealeLaurent Seroude
Jan 10, 2006·Urology·Ziya KirkaliJeff Weider

❮ Previous
Next ❯

Citations

Jul 23, 2014·Nature Reviews. Urology·S Bruce Malkowicz
Jun 23, 2011·Expert Review of Vaccines·Byram W Bridle
Jul 23, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Marian Vila-CaballerStefano Salmaso
Sep 27, 2018·Nature Reviews. Urology·Wei Shen Tan, John D Kelly
Jul 28, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nada OršolićDarko Kučan

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Anticancer Therapy
Adam R Metwalli, Ashish M Kamat
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
C Zarogianni, C Tsiamis
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
J Irani
© 2021 Meta ULC. All rights reserved